AstraZeneca's (AZN) roxadustat gets a second marketing approval in China for treating anaemia caused by chronic kidney disease in non-dialysis-dependent patients.

source https://finance.yahoo.com/news/astrazenecas-kidney-drug-roxadustat-gets-220810513.html?.tsrc=rss